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1. Introduction 
Gastritis represents an inflammation of the stomach lining in response to injury. It is either 
acute or chronic, and has many underlying causes which can be diagnosed and classified 
histologically where endoscopic appearances such as redness are often misleading. Gastritis 
is seldom if ever symptomatic, but usually have important clinical sequelae, principally 
duodenal and gastric ulceration, gastric adenocarcinoma and primary gastric lymphoma 
(El-Zimaity, 2007; Thirumurthi & Lanza 2010). The three most important causes of gastritis 
are categorized as Helicobacter pylori infection, prolonged use of aspirin, non-steroidal anti 
inflammatory drugs (NSAIDs) and autoimmunity (Dohil & Hassall, 2011). 
1.1 Acute gastritis 
Acute gastritis, is usually a diffuse and intense mucosal alteration, mostly is characterized 
by a sudden onset of symptoms and rapid resolution after the underlying aetiological 
mechanisms or agents (either chemical or physical) have been corrected. The patients can 
present with an acute gastroenteritis-like illness, or other symptoms which may be 
overshadowed by their general physical condition. Broadly speaking, acute gastritis arises 
when there is an acute imbalance between mucosal injury and repair mechanisms (Fig. 1) 
and can be organized in three groups based on the aetiologies: (i) infectious gastritis (ii) 
secondary to caustic injury; and (iii) ulcero-haemorrhagic (Srivastava & Lauwers, 2007). 
 
 
 
 
Fig. 1. Acute gastritis. Erosion and complete effacement of the epithelium is observed. The 
residual glands, on the left, display regenerative changes with basophilic epithelium. 
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No correlation may be exist between microscopic inflammation (histologic gastritis) and the 
presence of gastric symptoms (eg, abdominal pain, nausea, vomiting). In fact, most patients 
with histologic evidence of acute gastritis (inflammation) are asymptomatic. The diagnosis 
is usually obtained during endoscopy performed for other reasons. Acute gastritis may 
present with an array of symptoms, the most common being nondescript epigastric 
discomfort. Other symptoms include nausea, vomiting, loss of appetite, belching, and 
bloating. Fever, chills may be present. The diagnosis of acute gastritis may be clarified from 
the patient's history and can be confirmed histologically by biopsy specimens taken at 
endoscopy. Epidemiologic studies reflect the widespread incidence of gastritis (Ford et al., 
2010). 
1.1.1 Pathophysiology 
Acute gastritis has a number of causes, including certain drugs; alcohol; bile; ischemia; 
bacterial, viral, and fungal infections; acute stress (shock); radiation; allergy, food poisoning; 
and direct trauma. The common mechanism of injury is an imbalance between the 
aggressive and the defensive factors that maintain the integrity of the gastric mucosal lining 
(mucosa) (Kasper et al., 2006). 
Acute erosive gastritis can result from the exposure to a variety of agents or factors, referred to 
as reactive gastritis. These agents/factors include nonsteroidal anti-inflammatory medications 
(NSAIDs), alcohol, cocaine, stress, radiation, bile reflux, and ischemia. The gastric mucosa 
exhibits hemorrhages, erosions, and ulcers. NSAIDs, such as aspirin, ibuprofen, and naproxen, 
are the most common agents associated with acute erosive gastritis, mostly attributed to 
therapeutic. Major injury is attributed to reduced prostaglandin synthesis. Prostaglandins 
are chemicals responsible for maintaining mechanisms that result in the protection of the 
mucosa from the injurious effects of the gastric acid.  
Bacterial infection is another cause of acute gastritis. The corkscrew-shaped bacterium called 
H. pylori is the most common cause of gastritis. Complications result from a chronic 
infection rather than from an acute infection. The prevalence of H. pylori in otherwise 
healthy individuals varies depending on age, socioeconomic class, country of origin where 
the infection is usually acquired in childhood. In the Western world, the number of people 
infected with H pylori increases with age. Evidence of H. pylori infection can be found in 
20% of individuals younger than 40 years and in 50% of individuals older than 60 years. 
Transmission is likely from person to person through the oral-fecal route or through the 
ingestion of contaminated water or food. This is why the prevalence is higher in lower 
socioeconomic classes and in developing countries.  H pylori is associated with 60% of 
gastric ulcers and 80% of duodenalulcers (Andersen, 2007). 
H. pylori gastritis typically starts as an acute gastritis in the antrum, causing intense 
inflammation, and over time, it may extend to involve the entire gastric mucosa resulting in 
chronic gastritis. The acute gastritis encountered with H. pylori is usually asymptomatic. 
The bacterium imbeds itself in the mucous layer, a protective layer that coats the gastric 
mucosa. It protects itself from the acidity of the stomach through the production of large 
amounts of urease, an enzyme that catalyzes the breakdown of urea to the alkaline ammonia 
and carbon dioxide. The alkaline ammonia neutralizes the gastric acid in the immediate 
vicinity of the bacterium conferring protection. H. pylori also has flagella that enable it to 
move and help it to penetrate the mucous layer so that it comes into contact with gastric 
epithelial cells. It also has several adhesions that help it to adhere to these cells. It produces 
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inflammation by activating a number of toxins and enzymes that activate IL-8, which 
eventually attracts polymorphs and monocytes that cause acute gastritis (Fig. 2) (Das & 
Paul, 2007). 
 
 
Fig. 2. Proposed interaction between host, environment and H. pylori infection in the 
development of gastric and doudenal ulcers. 
Antigen-presenting cells activate lymphocytes and other mononuclear cells that lead to 
chronic superficial gastritis. The infection is established within a few weeks after the primary 
exposure to H. pylori. The intense inflammation can result in the loss of gastric glands 
responsible for the production of acid and mostly referred to as atrophic gastritis consequently 
production of gastric acid drops. The virulence genotype of the microbe is an important 
determinant for the severity of the gastritis of intestinal metaplasia transformation of gastric 
epithelium which can lead to gastric cancer (Soltermann et al., 2007). 
Reactive gastropathy is the second most common diagnosis made on gastric biopsy 
specimens after H. pylori gastritis. It is now considered to represent a nonspecific response 
to a variety of other gastric irritants (Owen, 2003). 
Tuberculosis is a rare cause of gastritis and generally associated with generally associated 
pulmonary or disseminated disease (Marshall, 1993) where secondary syphilis of the 
stomach is a rare cause of gastritis (Chen et al., 2006). 
Phlegmonous gastritis is an uncommon form of gastritis (rare) caused by numerous 
bacterial agents, including streptococci, staphylococci, Proteus species, Clostridium species, 
www.intechopen.com
 
Gastritis and Gastric Cancer – New Insights in Gastroprotection, Diagnosis and Treatments 
 
130 
and Escherichia coli. Phlegmonous gastritis usually occurs in individuals who are 
debilitated. It is associated with a recent large intake of alcohol, a concomitant upper 
respiratory tract infection, and AIDS. Phlegmonous means a diffuse spreading inflammation 
of or within connective tissue. In the stomach, it implies infection of the deeper layers of the 
stomach (submucosa and muscularis).  
Viral infections can cause gastritis either localized or diffuse and cytomegalovirus (CMV) is 
a common viral cause. It is usually encountered in individuals who are 
immunocompromised, including those with cancer, immunosuppression, transplants, AIDS 
with a localized or diffuse involvement to the gastric tissuesand AIDS (Bonnet et al., 2001; 
Sepulveda & Patil, 2008). 
Fungal infections that cause gastritis include Candida albicans and histoplasmosis. Gastric 
phycomycosis is another rare lethal fungal infection. The common predisposing factor is 
immunosuppression. C albicans rarely involves the gastric mucosa and when isolated in the 
stomach, the most common locations tend to be within a gastric ulcer or an erosion bed and 
it is generally of little consequence. Disseminated histoplasmosis can involve the stomach. 
The usual presenting clinical feature is bleeding from gastric ulcers or erosions on giant 
gastric folds (Lauwers et al., 2010). 
Parasitic infections are rare causes of gastritis. Anisakidosis is caused by a nematode that 
embeds itself in the gastric mucosa along the greater curvature. Anisakidosis is acquired by 
eating contaminated sushi and other types of contaminated raw fish. It often causes severe 
abdominal pain that subsides within a few days and this nematode infection is associated 
with gastric fold swelling, erosions, and ulcers (Kim et al., 2003). 
Ulcero-hemorrhagic gastritis is most commonly seen in patients who are critically ill and it is 
believed to be secondary to ischemia related to hypotension and shock or to the release of vaso 
constrictive substances but the etiology is often unknown. The gastric mucosa reveals multiple 
petechiae, mostly in the fundus and body, or exhibits a diffusely hemorrhagic pattern. The 
gross pathology may resemble that of NSAID- or other ingestion-induced gastritis except that 
the location of injury is different. This form of gastritis can be life-threatening if the patient 
experiences hemorrhaging and may even require emergency gastrectomy (Chamberlain, 1993). 
Microscopic evidence of acute gastritis can be seen in patients with Crohn disease, though 
clinical manifestations are rare (occurring in only about 2-7% of patients with Crohn 
disease). Focally enhancing gastritis is now recognized as a condition seen in both Crohn 
disease and ulcerative colitis (Xin & Greenson, 2004). 
Eosinophilic gastritis is often seen in conjunction with eosinophilic gastroenteritis but can be 
associated with various disorders, including food allergies (eg, cow milk, soy protein), 
collagen vascular diseases, parasitic infections, gastric cancer, lymphoma, Crohn disease, 
vasculitis, drug allergies, and H. pylori infections. An eosinophilic infiltrate is seen 
involving the gastric wall or epithelium (Rothenberg, 2004). 
1.2 Chronic gastritis 
Chronic gastritis is caused mainly by Helicobacter pylori infection, and nonatrophic gastritis 
progresses to atrophic gastritis for a long period. It is characterized by the presence of 
chronic inflammatory infiltrate in the gastric mucosa (Fig. 4). H. pylori-atrophic gastritis is 
strongly associated with gastric cancers, and its diagnosis is very important. It is diagnosed 
histologically according to the Updated Sydney System, which is now widely used in the 
world (Satoh et al., 2008). Chronic gastritis can be classified on the base of the underlying 
etiologic agent (eg, Helicobacter pylori, bile reflux, nonsteroidal anti-inflammatory drugs 
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[NSAIDs], autoimmunity, allergic response) and the histopathologic pattern, which may 
suggest the etiologic agent and clinical course (eg, H pylori –associated multifocal atrophic 
gastritis). Other classifications are based on the endoscopic appearance of the gastric mucosa 
(eg, varioliform gastritis) (Rugge & Genta, 2005). 
1.2.1 Pathophysiology 
The pathophysiology of chronic gastritis complicating a systemic disease, such as hepatic 
cirrhosis, uremia, or another infection is described in the relevant disease (Boulton et al., 
2011). The pathogenesis of the most common forms of gastritis is described as follows. 
  
 
 
 
Fig. 3. Chronic gatritis showing inflammation of mucosa linning 
The host response to H. pylori and bacterial products is composed of T- and B-cell 
lymphocytes, denoting chronic gastritis, followed by infiltration of the lamina propria and 
gastric epithelium by polymorphonuclear leukocytes that eventually phagocytize the 
bacteria. The presence of polymorphonuclear leukocytes in the gastric mucosa is diagnostic 
of active gastritis. The interaction of H pylori with the surface mucosa results in the release 
of proinflammatory cytokine interleukin (IL)-8, which leads to recruitment of 
polymorphonuclear cells and may begin the entire inflammatory process. Gastric epithelial 
cells express class II molecules, which may increase the inflammatory response by 
presenting H pylori antigens, leading to further cytokine release and more inflammation. 
High levels of cytokines, particularly tumor necrosis factor-a (TNF-α) and multiple 
interleukins (eg, IL-6, IL-8, IL-10), are detected in the gastric mucosa of patients with H. 
pylori gastritis (Zalewska-Ziob et al., 2009).  
In subsequent or joining such inflammation pattern is an increase in oxidative damage due 
to high level of ROS and increased apoptosis level in human gastric mucosa (obst et al., 
2000; cover et al., 2003). Infection also leads to the expression of inducible nitric oxide 
synthase ( iNOS) in host macrophage and polymorphnuclear leukocytes (Tari et al., 2003). 
NO produced by these cells infiltrating the gastric mucosa may damage DNA. Interaction 
between NO and superoxide anion can form peroxinitrite, potent nitrating agent leading to 
apoptosis in a variety of cell types (yue et al., 2001). 
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Prostaglandins especially PGE2 in the stomach play an important role in the maintenance of 
gastric mucosal integrity via several mechanism including regulation of gastric mucosal 
blood flow, kinetic of epithelial cells, synthesis of mucous, inhibition of gastric acid secretion 
and referring to its protective potential to gastric mucosa (Takeeda et al., 2004). 
Patients having Hpylori infection demonstrate significant gastremia which is mostly 
attributed to intragastric increase of H pylori inducing corpus atrophy and G cells damage 
in the antrum part. It may be also depends on alkalinization in G cells environment caused 
by H pylori urease (walsh et al., 1976; shacter et al., 2002). 
Serum pepsinogens (1&11) are higher also and specifically in patient category having IgM 
positive as compared to others (IgM-ve). This may be attributed to a polypeptides secreted 
by HP during earlier infection which stimulates chief cells directly and promote pepsinogen 
synthesis (Takeeda et al., 2004; kist, 1991; Elseweidy et al., 2010 a;b). 
This led certain study (Kekki et al., 1991) to consider serum pepsinogen level-as a non 
endoscopic blood test in the diagnosis of atrophic gastritis, HP eradication and, a screening 
tool for high risk subjects having atrophic gastritis rather than a test for cancer itself. 
Generally known Hp infection is associated with special local and systemic immune 
response. Early after 18 days of infection IgM response is detectable while IgG, IgA response 
occurs later after 60 days of infection at which time IgG titers decline. IgG, IgA serology is 
widely used as an accurate test for the diagnosis of Hp infection but those 2 
immunoglobulins remains detectable after eradication of HP and d'not demonstrate the 
infection status (acute, chronic or previously treated infection). Therefore the use of IgM test 
would allow for direct screening of the sample and serve as a diagnostic tool for establishing 
active or recent infection (Alem et al., 2002, Elseweidy et al 2010). 
Accordingly many authors concluded that diagnosis of atrophic gastritis using test panel of 
seum gastrin 17, pepsinogen 1, HP antibodies were in good agreement with endoscopic and 
biopsy findings, considering such panel a non endoscopic diagnostic and screening tool 
(vaananen et al., 2003). 
 
 
 
Fig. 4. Histological section of human fundic gland of patient suffering from gastritis with 
anti H. pylori IgM positive group showing (a) x100 irregular short fundic gland (FG), wide 
gastric pit (GP), multiple inflammatory cells (arrows) and blood vessels (double arrows) 
filling lamina propria (LP), (b) x400 showing irregular simple columnar epithelium (E), 
small pyknotic nuclei (arrows) of cells lyning fundic gland (FG) and multiple inflammatory 
cells (double arrows) filling lamina propria (LP) (Elseweidy et al., 2010 a). 
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2. Natural products used in treating gastritis 
Phenolic compounds, which include tannins and flavonoids, are apparently related to the 
interesting anti-inflammatory, woundhealing, antioxidant and antiulcerogenic properties to 
several medicinal plants (Moleiro et al., 2009). 
Tannins are potent scavengers of peroxyl radicals and can also interact with mucus proteins, 
improving their cytoprotective effect by forming a protein lining over the gastrointestinal 
mucosa (Okuda, 2005; Moleiro et al., 2009).  
Fresh fruit and vegetables have been reported to exert multiple biological effects on the 
mucosa of the gastrointestinal tract due to their antioxidant contents (La Vecchia & Tavani, 
1998). In particular, a diet rich in vegetable is associated with a lower incidence of gastric 
tumours (Roukos et al., 2003). 
Apart from their action as radical scavengers, phenolic compounds also have several 
indirect effects; they can inhibit lipoxygenase (Laughton et al., 1991), reduce platelet 
aggregation (Ferro-Luzzi & Ghiselli, 1993) and reduce the bioavailability of food carcinogens 
(Stavric, 1994). Certain flavonoids or compounds with flavonoid-like properties have 
antiulcer activity and can prevent gastric mucosal lining lesions brought about by a number 
of ulcerogens (Alarcon de la Lastra et al., 2002). 
Certain polyphenolics can exert a preventive action on gastric injury in rats.  Research topics 
her have focussed on the antiulcer activity of polyphenol from grape seed (Saito et al.,  
1998), cacao liquor (Osakabe et al., 1998), curcuminoids and Black seed oil  (Elseweidy et al., 
2008) or from Opuntia ficus indica (Galati et al., 2003). This activity was mainly explained by 
the strong antioxidant power and/or by some other factors, such as strong protein-binding 
capacity (Saito et al., 1998), modulation of leukocyte function (Osakabe et al., 1998), mucus 
production and restoration (Galati et al., 2003).  It is believed that the antioxidant activity of 
polyphenols is an important factor to combat the potential of free radicals. 
2.1 Morinda citrifolia aqueous fruit extract 
Morinda citrifolia L. (Rubiaceae), commonly known worldwide as “Noni” or so called in 
Thai as “Yor” is regularly consumed as food, additionally as medicinal plants used in 
primary health care. The decoction or infusion of roasted mature unripe fruits is 
recommended to relieve the symptoms of nausea and vomiting, if it is not too severe. 
According to the claimed efficacies in Thai traditional textbooks, the fruit is also used for 
treatment of various gastrointestinal disorders as a carminative, appetite stimulant, and 
reliever of gum diseases, heartburn or stomachache. Nevertheless, experimental studies 
demonstrated the preventive activity of an ethyl acetate extract of the fruit against acute 
gastric lesions induced by ethanol, aspirin and pyloric ligation; and acute duodenal ulcer 
induced by cysteamine in rats (Muralidharan & Srikanth, 2009). This extract was claimed to 
exhibit potent antioxidant properties and the active components are thought to be non-polar 
lignans (Kamiya et al., 2004). Previous studies of the effect of an aqueous fruit extract on 
gastrointestinal motility reported controversial results with increase (Chuthaputti et al., 
1996) and delay (Pu et al., 2004) gastric emptying action.  
It has been claimed also that aqueous extract have anti-inflammatory (McKoy et al., 2002) 
and antioxidative activities (Ikeda et al., 2009) in several in vitro test systems. Among a 
number of major components identified in the aqueous fruit juice, scopoletin, a coumarin 
derivative, as one of the main compounds that has known pharmacological activities 
especially an ability to control the serotonin level in the body (Levand and Larson, 1979), 
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together with anti-inflammatory (Deng et al., 2007; Moon et al., 2007) and antioxidative 
activities (Ikeda et al., 2009). Scopoletin is also recommended as a marker constituent for the 
quality control and pharmacokinetic study of Noni products (Samoylenko et al., 2006). 
This aqueous fruit extract as well as its biomarker: scopoletin, may be beneficial as a 
potential preventive and therapeutic agent for gastro-esophageal inflammation. This is 
mainly through its antisecretory and prokinetic activities including its ability to enhance the 
mucosal defensive mechanisms. Their efficacy was compared with a standard potent 
antisecretory proton pump inhibitor (lansoprazole) and referring to its stronger prokinetic 
efficacy in accelerating gastric emptying and intestinal transit in rats. These observed 
beneficial effects of AFE may be accounted for by one of its major active biological 
components scopoletin (Mahattanadul et al., 2011). 
2.2 Quercetin-3-O-β-D-glucuronopyranoside (QGC), isolated from Rumex Aquaticus 
herb 
It is well known that flavonoids which have anti-inflammatory, antioxidant, antiallergic, 
hepatoprotective, antithrombotic, antiviral, and anticarcinogenic activities. As reported 
before the anti-inflammatory activities of flavonoids demonstrate their candidacy as 
therapeutic agents (Lewis, 1989). The flavonoids are typical phenolic compounds that act as 
potent metal chelators, antioxidants and free radical scavengers, which modulate 
intracellular signaling caused by upstream binding partners, such as, regulatory kinases and 
receptors (Williams et al., 2004a).  
Such flavonoid is a natural flavone with various bioactivities and was found to be highly 
efficient to scavenge free radicals in cell-free systems (Rice-Evans et al., 1996), as compared 
to traditional antioxidants like vitamin C and E (Geetha et al., 2005). Gerritsen et al., (1995) 
found that flavonoids, especially an apigenin, blocked the cytokine-induced expressions of 
intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), 
and E-selectin on human endothelial cells.  
Regarding gastric secretion, the oral administration of QGC reduced gastric content 
significantly, dose-dependently, and prevented the development of reflux esophagitis. 
These results suggest that QGC has inhibitory effects on reflux esophagitis and gastritis in 
rats. Furthermore, in feline esophageal epithelial cells, QGC was found to have a protective 
effect on ethanol induced cell damage by inhibiting ROS generation, activation downstream 
of ERK (Min et al., 2009), and downstream signal transduction induced by interleukin-1 beta 
(Lee et al., 2009a). 
2.3 The aqueous decoction of mango flowers (Mangifera indica L.) 
Mangifera indica L. (Anacardiaceae) is a large tree that grows in tropical and subtropical 
regions. The Caribbean population used aqueous decoction from M. indica flowers for the 
treatment of gastritis and gastric ulcer. Phytochemical research from different parts of M. 
indica has demonstrated the presence of phenolics, triterpenes, flavonoids, phytosterols and 
polyphenols (Selles et al., 2002; Singh et al., 2004). 
Garrido et al., (2004) reported the antinociceptive and anti-inflammatory activities of 
Vimang®, an aqueous extract obtained from M. indica. They attributed these activities to 
their inhibitory influence on the prostaglandin synthesis through arachidonic acid 
metabolism additionally production of reactive oxygen species. Tordera et al., (1994) 
demonstrated the influence of several anti-inflammatory flavonoids present in M. indica on 
mast cell degranulation and arachidonic acid release in rats. 
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M. indica is also described as an antioxidant agent (Sanchez et al., 2003). Oxygen-derived 
free radicals have been postulated to play an important role in the pathogenesis of acute 
gastric mucosal injuries such as those induced by stress (Hariganesh & Prathiba, 2000), 
ethanol (Salim, 1990) and NSAIDs (Pihan et al., 1987) and scavenging of these radicals can 
stimulate the healing process.  This was illustrated before in experimental model induced by 
acetic acid and attributed mainly to their high content of flavonoids (Naito et al., 1995).  
2.4 Abarema cochliacarpos 
Several medicinal plants including species of the Brazilian Cerrado biome as well as plants 
of the “Caatinga” biome contain phenolic compounds like tannins and flavonoids that have 
anti-inflammatory, antioxidant and antiulcerogenic properties (Almeida et al., 2005; Moleiro 
et al., 2009). 
Catechins (flavan-3-ols) such as catechin, epicatechin, epigallocatechin, epicatechin gallate 
and epigallocatechin gallate, are particularly abundant in the bark of the species of 
Mimosaceae family (Santos et al., 2002). These compounds has anti-inflammatory and anti 
cholesterolemic effects additionally protective agent against cytotoxicity owing to their 
antioxidant properties (Williams et al., 2004b). 
Araujo et al. (2008) studied plants with elevated levels of phenolic compounds within 
specific groups of plants for further therapeutic applications. They concluded that Caatinga 
medicinal plants, which are known and/or used for their wound-healing or anti-
inflammatory properties, tend to have high tannin contents. Moreover, these compounds 
appear markedly elevated in some species, such as Abarema cochliacarpos, that are 
intensively used by the local communities (Monteiro et al., 2006). 
Abarema cochliacarpos is a plant native to Brazil, occurring mainly in the Atlantic Forest 
and in the Caatinga biomes. It is a tree species of the legume family Mimosaceae 
(International Union for Conservation of Nature "IUCN", 2009), which is popularly known 
as “barbatimao”. In this community, the decoction of the bark is utilized to wash external 
ulcers while its tincture, (bark immersed in white wine) “cachaca”, or ingested form is used 
against inflammation and gastric ulcers, among other uses (Silva et al., 2006). Other authors 
also observed similar applications in different traditional communities (Agra et al., 2008). 
As to pharmacologic effects, the hydroalcoholic extract from the bark of Abarema 
cochliacarpos showed antimicrobial activity. Both crude aqueous and methanol extracts also 
showed antinociceptive effects (Silva et al., 2009). Butanolic fraction of the methanolic 
extract was tested recently in a model of acute experimental trinitrobenzene sulfonic acid 
(TNBS)-induced colitis and showed anti-inflammatory effects (Silva et al., 2010a). 
It has been suggested that Abarema cochliacarpos (Gomes) Barneby & Grimes extracts 
exerts gastroprotective effects and wound healing properties in the ethanol-induced ulcer 
model. The safety and efficacy in the healing of gastric ulcers is based on its ability to 
activate the expression of COX-2, vascular-endothelial growth factor (VEGF) and stimulate 
proliferative factors like HSP-70 that re-establish the gastric mucosa integrity (Silva et al., 
2010b). 
2.5 Apple polyphenol extracts 
Eberhardt and colleagues (2000) illustrated the antiproliferative effect of apple extract in 
vitro using tumor cells and attributed such effect to the presence of phytochemicals 
(phenolic acids and flavonoids) other than ascorbic acid. Therefore, dietary antioxidants 
play a crucial role in the maintenance of gastric homeostasis by counteracting the potentially 
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mucosal damage exerted by ROS. This may explain the role of dietary antioxidants as 
scavenger of oxygen, nitrogen free radicals and breaking lipid peroxisdation reactions. 
Phenolic compounds are one of the major classes of dietary antioxidants and apple phenolic 
compounds represent 22 percent of such total (Le Marchand et al., 2000). 
In vitro and in vivo studies demonstrated the protective effect of apple juice regarding 
gastric mucosa of rat. This was markedly observed in gastric injury model induced by 
aspirin and independently of its inhibition to gastric acid. Therefore it might be of 
therapeutic benefit in prophylaxis of aspirin- related gastropathy (D' argenio et al., 2008). 
Accordingly a diet rich in apple antioxidants might exert a beneficial effect in gastric 
diseases associated with generation of reactive oxygen species (Graziani et al., 2005). 
2.6 Foeniculum vulgare (Fennel) 
Foeniculum vulgare (FVE) is a well-known umbelliferous plant. For centuries, FVE fruits 
have been used as traditional herbal medicine in Europe and China. It is native to southern 
Europe and the Mediterranean area. The seeds of this plant have been used to regulate 
menstruation, alleviate the symptoms of female climacteric syndrome, and increase libido 
(Albert-Puleo, 1980). FVE also possesses emnenagague, galactagogue and antispasmodic 
properties additionally in folk remedies for treatment of dysmenorrheal, also as diuretic and 
wound dressing in Turkish traditional medicine (Savino et al., 2005).  
It contains 1%-3% of a volatile oil, which is composed of 50%-85% of anethole and about 
20% of d-fenchone (Dadalioglu & Evrendilek, 2004). Other compunds present in FVE are d-
a-pinene, d-a-phellandrene, dipentene, methyl chavicol, feniculun, anisaldehyde, and anisic 
acid (Mimica-Dukic et al., 2003). 
Previous studies proved that anethole possesses significant antioxidant, anti-inflammatory 
and ulcer healing activity in experimental models (Freire et al., 2005). Additionally, 
flavonoids, sterols, tannins and coumarins of some plants are also known to possess 
antiulcer activity (Khalil, 2006). Therefore, the presence of flavonoids content and other 
bioactive compounds in FVE may be beneficial in ulcer therapy. Its gastro protective effect 
has been also observed before in certain gastric mucosal lesion induced by ethanol, 
attributed mostly to its antioxidant activity and reduction of lipid peroxidation cascade.  
Therefore it may be a new alternative for clinical management of gastric ulcer diseases 
and/or an antioxidant against oxidative stress (Birdane et al., 2007). 
2.7 Flavonoids isolated from Piper carpunya Ruiz & Pav 
The leaves of Piper carpunya Ruiz & Pav. (syn Piper lenticellosum C.D.C.) (Piperaceae), 
known with the popular name of “guaviduca” in Ecuador are widely used in folk medicine 
in tropical and subtropical countries of South America, as an anti-inflammatory, anti-ulcer, 
anti-diarrheal and anti-parasitical remedy as well as an ailment for skin irritations. The 
antiinflammatory activity has been confirmed in rat models like the carrageenan-induced 
paw edema and the results obtained can support its use in the traditional medicine of 
Ecuador (De las Heras et al., 1998). Recently, this plant has been shown to protect against 
gastric ulcers induced by non-steroidal anti-inflammatory drugs (NSAID) in rats (Trabadela 
et al., 2009).  
Numerous plant remedies have shown to be active against Helicobacter pylori infection, 
such as the oil extract of Chamomilla recutita (Shikov et al., 2008), the ethanolic extract of 
Cuminum cyminum L., Propolis (Nostro et al., 2005) as well as the methanolic extract of 
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Alchornea triplinervia (Spreng.) Mull. Arg., which exhibited anti-secretory, anti-
Helicobacter pylori and gastroprotective effects (Lima et al., 2008). 
Several mechanisms of action have been proposed to illustrate its anti-inflammatory effects. 
This may be explained through other properties such as anti-oxidant activity, inhibition of 
eicosanoid generating enzymes or as modulator for proinflammatory molecules. Recent 
studies have also shown that some flavonoids are modulators of proinflammatory gene 
expression (Garcia-Lafuente et al., 2009). Gastro protective activity of flavonoids may be 
through reducing gastric acid secretion and inhibition of gastric H+, K+-ATPase. One 
example is Baccharis illinita D.C., which is also used in folk medicine, and whose anti-
secretory activity is attributable to the flavonoid luteolin (Freitas et al., 2008). 
Furthermore, some flavonoids have also demonstrated inhibitory effects on Helicobacter 
pylori growth and vacuolation. Helicobacter pylori induces gastric epithelial cell apoptosis 
via secreted mediators such as the VacA cytotoxin and lipopolysacccharides which damage 
epithelial acid-secreting parietal cells (Neu et al., 2002). Several flavonoids have inhibitory 
influence on the apoptotic signaling induced by Helicobacter pylori VacA toxin (Xiao et al., 
2007). Antimicrobial compounds from plants may inhibit bacterial growth by different 
mechanisms and could therefore be useful in case of resistance state to antibiotics. In this 
way, Castillo-Juarez et al., (2007) found that the petroleum ether fraction from 
Amphipterygium adstringens (Schltdl.) Standl. had significant anti-microbial activity 
against Helicobacter pylori. From this fraction, the authors isolated a mixture of anacardic 
acids and three known triterpenes: masticadienonic acid, 3-alpha-hydroxymasticadienonic 
acid, 3-epi-oleanolic as well as the sterol ß-sitosterol. 
Previous study suggested that the flavonoids (vitexin, isovitexin, rhamnopyranosylvitexin 
and isoembigenin),  nervogenic acid and geranylbenzoate isolated from the ethanolic extract 
of Piper carpunya may contribute to the anti-myeloperoxidase activity, as well as to their 
anti-Helicobacter pylori effect. These flavonoids may also be responsible for the important 
inhibition of H+, K+-ATPase pathway, additionally the obtained phytosterols and phytol 
could be involved in these gastroprotective activities (Quilez et al., 2010). 
2.8 Quassia amara 
Quassia is a plant that grows typically in the American tropical regions (from Mexico to the 
Brazilian Amazona) below 500 m altitude, especially in the Caribbean side of Central 
America and the Pacific coast of Costa Rica and Panama. The plant prefers very humid 
environments, but it can be found in the dry forest next to a riverbank (López and Pérez, 
2008). 
Quassia amara L. is one of the most mentioned plants in ethnomedicine for the treatment of 
malaria, mainly in Surinam, Guyana and French Guyana, where tea cups are carved from 
the wood and the addition of hot water forms an infusion in them (Odonnea et al., 2007). 
There only exist a few studies on the gastrointestinal, digestive and secretagogue activity of 
Quassia amara L. extracts. The results point to an increase of bile secretion with a 
standardized extract, inhibition of ulcer induction with crude extracts, accompanied by a 
slight decrease in pH and peptic activity of gastric juice additionally  an  enhancement of 
cytoprotective factors like gastric mucus (Toma et al., 2002). 
The biological activity of Quassia amara L. has been attributed mainly to its high content of 
quassinoids. These metabolites are oxygenated triterpenes derived from euphol and are 
exclusive to the Simaroubaceae family. The most important quassinoids in Quassia amara L. 
are quassin and neoquassin. Quassin is one of the most bitter substances known, it 
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represents 0.1% of the dried weight of wood and bark, and it is present in larger quantities 
when the plant is grown in the shade (Guo et al., 2005).  
Quassia amara L. bark standardized extracts, Lipro® and Ligas®, which were standardized 
to its quassinoid content, showed an important anti-ulcerogenic and gastroprotective 
potential in acute ulcer induction models. Their effect was related to an increase in gastric 
barrier mucus and non protein sulfhydril groups (Garcia-Barrantes & Badilla, 2011). Gastric 
barrier mucus is an important factor in gastroprotection (Kaunitz, 1999). Animals treated 
with Ligas® showed substantial mucus production. Prostaglandins I2, E2 and F2 are some 
of the main stimuli for the production of gastric and duodenal mucus (Dharmani et al., 
2005). The increase in mucus could be a signal of the role of prostaglandins in the anti-
ulcerogenic properties of the extracts. 
2.9 Gardenia jasminoides Ellis ethanol extract 
Gardenia jasminoides Ellis (GJE), has been used in traditional oriental medicine for the 
treatment of jaundice, fever, hypertension, and ulcers of a skin (Tseng et al., 1995). It has 
been reported that the crude extract of GJE fruit has biological and pharmacological 
activities. In the phytochemical studies of GJE, genipin, chlorogenic acid, rutin, and ursolic 
acid were detected in GJE extracts (He et al., 2006). Genipin is an aglycone derived from an 
iridoid glycoside called geniposide present in fruit of GJE, and is an excellent natural cross-
linker for proteins, collagen, gelatin, and chitosan cross-linking. It has been also used for 
pharmaceutical purposes, such as choleretic action for liver diseases control, and the relief of 
type 2 diabetes symptoms. Ursolic acid is a pentacyclic triterpene acid, used in cosmetics 
(Shishodia et al., 2003), and as inhibitor for various types of cancer cells by inhibiting the 
STAT3 activation pathway (Pathak et al., 2007) and human fibrosarcoma cells by reducing 
the expression of matrix metalloproteinase-9 by the glucocorticoid receptor. 
Gastric cancer is the second commonest cause of death from malignant disease worldwide 
(Neugut et al., 1996). Antioxidant compounds, such as vitamin C and E, have a key role for 
prevention and termination of development of gastric cancer (Block, 1991). It has been 
recognized that chronic infections of the gastric mucosa by Helicobater pylori (H. pylori) 
plays a pivotal role in gastric carcinogenesis. Such infection usually causes acute and chronic 
inflammation cell infiltrate, leading to an increase of reactive oxygen species (ROS), which 
are highly reactive compounds. The latter may combine with DNA in a number of 
potentially genotoxic ways, subsequently accumulated in H. pylori gastritis. Therefore it 
may be possible to prevent carcinogenesis through reduction of ROS damage to cellular 
constituents, especially DNA, additionally the eradication of H. pylori can lead to a 
reduction in ROS activity in the gastric mucosa (Drake et al., 1998). 
Lee et al., (2009b) in confirm indicated that the ethanolic extracts of GJE exerted protective 
activities against potential gastritic diseases like gastritis and gastric cancer. This action 
might be due to antioxidant activity, anti-H. pylori activity of ursolic acid and genipin that 
counteract free radicals  exerting anti-ulcer activity. 
2.10 Curcumin 
Curcumin, the polyphenolic yellowish pigment of the rhizome Curcuma longa Linn, is 
known to possess anti-inflammatory, antioxidant, wound-healing, and antiallergic activities 
(Das& Das, 2002). Several investigators have also reported the antiulcerogenic activity of the 
ethanolic extract of the rhizome of C. longa in acute gastric mucosal lesion (Rafatullah et., 
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1990), but not in chronic ulcer models. More recently, it has been considered that curcumin 
exerts a variety of pharmacological actions through inhibition of inducible nitric oxide 
synthase (iNOS) as well as its potential as radical scavenger (Elseweidy et al., 2008) Thus, 
the previously proposed mechanisms for antiulcerogenic effect of curcumin (Yano et al., 
2000), such as inhibitory effect on gastric secretion, cytoprotection, antioxidant activity and 
inhibition of mast-cell degranulation, need to be evaluated again. 
Curcumin, exerted its preventive effect on gastric lesion formation, although it possesses 
anti-inflammatory activity resulting from a blockade of all branches of the arachidonic acid 
pathway (Ammon et al., 1993). This effect is consistent with the findings reported by several 
authors that the inhibition of prostaglandins synthesis is unlikely to be the mechanism 
responsible for the inflammatory ulceration formation.  Curcumin therefore may exert this 
through its antioxidant activity and its inhibition of nuclear factor kappa B activation which 
up-regulates many genes involved in inflammation and immunity, including its potent 
suppressive effect on mast-cell degranulation (Jobin et al., 1999). Although there is a 
potential increase of gastric acid secretion with a high dose of curcumin, gastric acid 
secretion has been found to play little role in the pathogenesis of this model (Ohta et al., 
1999). 
Apparent healing – promoting effect  of curcumin was also observed in gastric ulcer model, 
induced by acetic acid with an enhancement of  mucosal layer regeneration. This effect was 
not seen in a dose-related fashion, presumably through some curative mechanisms 
differently modified by curcumin dosage. Accordingly, it is conceivable that the effect of 
curcumin occurs at least partly through its inhibition of the cytokine-mediated 
inflammatory mechanism, suppression of iNOS activity and antioxidant activity as 
mentioned above. In addition, the curative properties and ulcer healing might result from 
the elevation of epidermal growth factor and transforming growth factor-beta-1, as shown 
in acceleration of cutaneous wound healing in rats, guinea pigs and mice (Sidhu et al., 1998).  
Another study attributed such preventive and curative effects of curcumin to an increase in 
the mucosal defensive mechanism through its antioxidant property, increase in mucin 
secretion and inhibition of NO or cytokine-mediated inflammation (Mahattanadul et al., 
2006). 
2.11 Artichoke leaf extract 
Artichoke (Cynara Scolymus L.) is a plant that is widely grown in Mediterranean countries, 
including southern France and California in the United States.  In general, the dried extract 
consisting of leaves and not flowering heads of artichoke has been eluted with water in 
European countries and the main components are caffeoylquinic acid derivatives (cynarin 
and chlorogenic acid), flavonoids (luteolin and apigenin) and bitters (cynaropicrin) (Joy & 
Haber, 2007). Artichoke leaf extract has been used for hepatoprotective and cholesterol 
reducing (Aktay et al., 2000) purposes. Based on in vitro (Perez-Garcia et al., 2000) and in 
vivo (Speroni et al., 2003) studies, it is believed that artichoke leaf extract is very effective as 
an antioxidant and its  leaf extract contains cynaropicrin and chlorogenic acid as the main 
components. It is currently used in Germany and Switzerland as a remedy for indigestion.  
And its better compounds such as cynariopicrin as inflammatory agents due to its inhibitory 
influence on inflammatory mediators (Holtmann et al., 2003). 
Previous results indicated that artichoke leaf extract is effective against acute hemorrhagic 
gastritis and its beneficial effect is due to that of cynaropicrin. The gastric mucus-increasing 
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action of artichoke leaf extract may be, at least in part, related to the anti-gastritic action of 
the extract (Ishida et al., 2010). 
2.12 Pear (Pyrus communis L.) procyanidins 
Some European pear (Pyrus communis L.) cultivars have been reported to contain 
significant amounts of polyphenols, such as chlorogenic acid, flavan-3-ols and arbutin. 
procyanidins are reported to have many beneficial properties, such as potent antioxidant 
activity (Zhu et al., 2002), free radical scavenging activity (Arteel & Sies, 1999), 
antiinflammatory activity and anti-influenza viral activity (Hamauzu et al.,  2005). 
It has been shown that procyanidins extracted from pear (Winter Nelis) fruit had a very high 
mean degree of polymerization (mDP), indicating that these compounds may interact with 
mucosa proteins. Accordingly the mechanism of mucosa protection by pear procyanidins 
may be both physical and chemical. By binding strongly to the mucosa, procyanidins build a 
protective layer against injury, reducing leukocyte migration, and then exerting its local 
antioxidant protection against free radicals (Hamauzu et al., 2007). 
2.13 Sesame lignan sesamol 
Sesamol (3,4-methylenedioxyphenol), the lignan of sesame oil, is a potent antioxidant and anti-
inflammatory agent in various oxidative systems, including endotoxin and iron intoxication 
(Hsu et al., 2007). Recent study has confirmed its effect in gastric haemorrhage model and 
mucosal ulcer induced in rats by aspirin. Sesamol her significantly reduced gastric mucosal 
lipid peroxidation, nitric oxide production, gastric mucosal proinflammatory cytokines (tumor 
necrosis factor-a and interleukin 1-ß levels), and the activity of gastric mucosal 
myeloperoxidase. This was attributed to an inhibition of neutrophil infiltration, subsequent 
gastric mucosal inflammation and oxidative stress in rats (Hsu et al., 2009a). It seems likely 
that sesamol protective influence on gastric mucosal injury may be at least partially through an 
inhibition of mucosal reactive nitrogen species and subsequent lipid peroxidation.  
Inhibition of neutrophils activation and their infiltration into gastric mucosa may be 
sesamol’s anti-inflammatory and antioxidative mechanism. Neutrophil activation and 
infiltration are crucial in the pathogenesis of NSAID-induced gastric inflammation and 
oxidative stress (Souza et al., 2008). Activating neutrophils results in the expression of 
proinflammatory genes and the overproduction of proinflammatory mediators, including 
TNF-α and IL-1ß, which initiates an inflammatory response (Jaeschke & Hasegawa, 2006).  
Overproduction of proinflammatory mediators can upregulate nitric oxide production 
leading to an increase of reactive nitrogen species, lipid peroxidation, and cell damage 
(Hayes and McLellan, 1999). Similar effect for Sesamol was also observed in the gastric 
mucosa of aspirin-treated rats preventing inturn gastric injury. This may be attributed to 
certain combination between sesamol and aspirin, inhibiting inturn neutrophil infiltration, 
mucosal inflammation and oxidative stress (Hsu et al., 2009a). 
Daily consumption of sesame or sesame oil may be beneficial in protecting against gastric 
mucosal damage induced by long-term use of NSAID. Sesame lignan sesamol is one of the 
important antioxidative components in sesame in addition to some other antioxidants such 
as sesamin, sesamolin, and gamma-tocopheral (Tokusoglu et al., 2003). All of them could 
attenuate NSAID initiated gastric mucosal oxidative stress. Therefore, we suggested that 
daily consumption of sesame or sesame oil could protect against NSAID-induced gastric 
mucosal damage. However, more investigations will be needed to confirm this. 
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Also, pretreatment of sesame oil, significantly decreased acidified ethanol-induced mucosal 
ulcer formation and luminal hemorrhage. Sesame oil her reduced mucosal lipid 
peroxidation, as well as glutathione and nitric oxide production in  experimental rats model 
attenuating in turn oxidative stress and gastric mucosal injury (Hsu et al., 2009b). 
3. Conclusion  
Gastritis represents  an inflammation of the stomach lining in response to injury.It is either 
acute or chronic and has many underlying  causes ,however the most  important of them are 
Helicobacter pylori (HP) infection, Autoimmunity additionally prolonged  uptake of certain 
drugs ,specifically aspirin and nonsteroidal antiinfilammatory drugs (NSAIDs).The common 
mechanism of an injury is an imbalance between  the aggressive and defensive factors  that 
maintain the integrity of the gastric lining (mucosa). In subsequent or joining such 
inflammation pattern an increase in oxidative damage due to high level of reactive oxygen 
species (ROS) , higher gastrin, pepsinogen, expression  of inducible nitric oxide synthase 
(iNOS) leading  to corpus atrophy and G cells damage. Interaction of NO and can form 
peroxynitrite, leading finally to apoptosis in a variety of cell types. 
Tannins and flavonoids (phenolic compounds) are commonly found in several medicinal 
plants. Certain therapeutic properties mainly anti-inflammatory, wound healing, 
antioxidant and anti ulcerogenic are mostly attributed to these plant constituents. 
Tannins are potent scavengers of per oxi radicals and can interact with mucus proteins, 
improving their cytoprotective effect by forming a protein lining over the gastrointestinal 
mucosa, additionally involved in wounds treatment. Fresh fruits and vegetables have been 
reported to exert multiple biological effects on the mucosa of gastrointestinal tract due to 
their antioxidants content. Certain flavonoids or compounds with flavonoid-like properties 
have antiulcer activity, prevent gastric mucosal lesions brought about by a number of 
ulcerogens. This had been illustrated before on polyphenol from grape seed, aqueous fruit 
extract of morinda citrifolia, Quarcetin, apple extract, curcumin, black seed oil, quassin, 
artichoke and others. It is conceivable that some of these plant constituents exerted their 
effects through the inhibition of cytokine-mediated inflammatory mechanism, suppression 
of iNOS, antioxidant activities and healing of the produced ulcer. 
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